This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Adjust your budget when income, expenses, or goals change, ensuring your plan remains aligned with long-term financial health.
22,799 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
A Perdoceo director recently exercised 9,308 options and sold shares, triggering questions for investors. This guide ...
As the RMD age rises to 73, near-retirees with sizable pre-tax accounts are weighing Roth conversions now to reduce t...
A 65-year-old widow faces a pivotal decision: switch to her own Social Security benefit now or wait, risking a smalle...
Elon Musk’s trillionaire status has pushed his net worth above the non-Bitcoin crypto market cap, signaling new tensi...
Austin reels after the death of Joshua Baer, the founder who helped mold the city’s tech economy. The loss raises que...
As Social Security nears a 2033 funding cliff, the politics of protection clash with actuarial reality. Markets and r...
Federal prosecutors have opened a grand jury investigation into allegations surrounding UAW President Shawn Fain, wit...
A partnership between Nike and Costco could unlock new growth by marrying premium branding with broad, loyalty-driven...
Jamie Dimon just turned 70, and a brush with a life-threatening health crisis years ago reshaped his view of success,...
Lululemon faces renewed headwinds as leadership shifts and governance questions surface. This comprehensive look brea...
A caller in his 60s with a six-figure income and no retirement savings since 2008 receives a blunt reality check on T...